Nutra Pharma Corp., a biopharmaceutical company, acquires, licenses, and commercializes pharmaceutical products and technologies, and homeopathic and ethical drugs for the management of pain, neurological disorders, cancer, and autoimmune and infectious diseases primarily in the United States. The company offers Nyloxin and Nyloxin Extra Strength products, which are used as an oral spray for treating back pain, neck pain, headaches, joint pain, migraines, and neuralgia, as well as a topical gel for treating joint pain, neck pain, arthritis pain, and pain associated with repetitive stress; Pet Pain-Away, an over-the-counter pain reliever to treat pain in cats and dogs; Luxury Feet, an over-the-counter pain reliever to treat foot pain from high heels and stilettos; Nyloxin Military Strength for treating pain to the United States Military and Veteran's Administration; and Equine Nyloxin, a topical therapy for chronic pain in horses. It is also developing RPI-78M to treat neurological diseases and autoimmune diseases, including multiple sclerosis, adrenomyeloneuropathy, amyotrophic lateral sclerosis, rheumatoid arthritis, and myasthenia gravis; RPI-MN to treat viral diseases, including human immunodeficiency virus/AIDS and herpes; RPI-78 for pain and arthritis; and RPI-70 for pain. The company has a collaboration agreement with the International Security Group to develop nerve agent counter measures. Nutra Pharma Corp. was founded in 2000 and is based in Coral Springs, Florida.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Sub-IndustryN/A
SectorMedical
Phone954-509-0911
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$120,000.00
Profitability
Miscellaneous
Employees4
Next Earnings Date3/25/2019 (Estimated)
OptionableNot Optionable
Nutra Pharma (OTCMKTS:NPHC) Frequently Asked Questions
What is Nutra Pharma's stock symbol?
Nutra Pharma trades on the OTCMKTS under the ticker symbol "NPHC."
How were Nutra Pharma's earnings last quarter?
Nutra Pharma Corp. (OTCMKTS:NPHC) announced its earnings results on Friday, August, 17th. The company reported $0.00 EPS for the quarter. The firm had revenue of $0.03 million for the quarter. View Nutra Pharma's Earnings History.
When is Nutra Pharma's next earnings date?
Has Nutra Pharma been receiving favorable news coverage?
News stories about NPHC stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nutra Pharma earned a news sentiment score of 1.7 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future.
Who are some of Nutra Pharma's key competitors?
What other stocks do shareholders of Nutra Pharma own?
Who are Nutra Pharma's key executives?
Nutra Pharma's management team includes the folowing people:
- Mr. Erik J. Deitsch, Chairman, CEO, Pres & CFO (Age 51)
- Dr. Dale VanderPutten, Chief Scientific Officer (Age 60)
- Mr. Neil Roth, Pres of Designer Diagnostics, Inc
- Ms. Nina Goldstein, Sec. (Age 59)
How do I buy shares of Nutra Pharma?
Shares of NPHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Nutra Pharma's stock price today?
One share of NPHC stock can currently be purchased for approximately $0.0003.
How big of a company is Nutra Pharma?
Nutra Pharma has a market capitalization of $600,000.00 and generates $120,000.00 in revenue each year. Nutra Pharma employs 4 workers across the globe.
What is Nutra Pharma's official website?
How can I contact Nutra Pharma?
Nutra Pharma's mailing address is 12538 WEST ATLANTIC BLVD., CORAL SPRINGS FL, 33071. The company can be reached via phone at 954-509-0911 or via email at [email protected]
MarketBeat Community Rating for Nutra Pharma (OTCMKTS NPHC)
MarketBeat's community ratings are surveys of what our community members think about Nutra Pharma and other stocks. Vote "Outperform" if you believe NPHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NPHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
